We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+14.94%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$114B
AUM Growth
+$18.7B
Cap. Flow
+$1.27B
Cap. Flow %
1.11%
Top 10 Hldgs %
12.43%
Holding
4,806
New
575
Increased
1,549
Reduced
1,464
Closed
527

Sector Composition

Rank Sector Weight
1 Technology 17.03%
2 Consumer Discretionary 9.51%
3 Healthcare 5.77%
4 Financials 5.47%
5 Communication Services 4.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BXP icon
1201
Boston Properties
BXP
$11.2B
$10.8M 0.01%
154,192
+65,259
+73% +$3.85M
SQSP
1202
DELISTED
Squarespace, Inc.
SQSP
$10.8M 0.01%
327,596
-16,722
-5% -$489K
LYV icon
1203
CALL
Live Nation Entertainment
LYV
$43B
$10.8M 0.01%
115,000
+25,000
+28% +$2.15M
CM icon
1204
PUT
Canadian Imperial Bank of Commerce
CM
$105B
$10.8M 0.01%
223,500
+123,500
+124% +$4.94M
CLS icon
1205
CALL
Celestica
CLS
$37.1B
$10.8M 0.01%
367,400
+219,100
+148% +$5.83M
IVZ icon
1206
Invesco
IVZ
$14.3B
$10.7M 0.01%
601,762
-1,433,944
-70% -$20.7M
VTLE
1207
DELISTED
Vital Energy
VTLE
$10.7M 0.01%
234,380
-49,532
-17% -$2.37M
FCNCA icon
1208
PUT
First Citizens BancShares
FCNCA
$24.7B
$10.6M 0.01%
7,500
-2,500
-25% -$3.51M
JBL icon
1209
CALL
Jabil
JBL
$31.9B
$10.6M 0.01%
83,400
-5,400
-6% -$688K
NSC icon
1210
CALL
Norfolk Southern
NSC
$79.3B
$10.6M 0.01%
+44,900
New +$9.41M
FCN icon
1211
FTI Consulting
FCN
$4.29B
$10.6M 0.01%
53,259
-18,119
-25% -$3.75M
WBD icon
1212
CALL
Warner Bros
WBD
$72B
$10.6M 0.01%
930,500
EYE icon
1213
National Vision
EYE
$1.44B
$10.6M 0.01%
504,709
-239,515
-32% -$4.25M
SBH icon
1214
Sally Beauty Holdings
SBH
$1.56B
$10.5M 0.01%
793,935
-261,023
-25% -$2.53M
AMP icon
1215
Ameriprise Financial
AMP
$49.6B
$10.5M 0.01%
27,712
-64,545
-70% -$22.1M
DOC icon
1216
Healthpeak Properties
DOC
$14.9B
$10.5M 0.01%
529,546
-580,082
-52% -$10.2M
PSX icon
1217
CALL
Phillips 66
PSX
$96.5B
$10.5M 0.01%
78,700
+22,100
+39% +$2.64M
BE icon
1218
CALL
Bloom Energy
BE
$60.1B
$10.4M 0.01%
705,400
+495,100
+235% +$6.19M
AR icon
1219
PUT
Antero Resources
AR
$11.7B
$10.4M 0.01%
460,200
+190,200
+70% +$4.82M
PBF icon
1220
PBF Energy
PBF
$8.24B
$10.4M 0.01%
237,305
-47,829
-17% -$2.17M
CBRE icon
1221
CBRE Group
CBRE
$44B
$10.4M 0.01%
111,896
-441,016
-80% -$34.3M
ADM icon
1222
CALL
Archer Daniels Midland
ADM
$37.7B
$10.4M 0.01%
143,600
+21,400
+18% +$1.57M
DXCM icon
1223
PUT
DexCom
DXCM
$34.4B
$10.4M 0.01%
83,500
+75,000
+882% +$7.66M
PFSI icon
1224
CALL
PennyMac Financial
PFSI
$3.91B
$10.4M 0.01%
117,200
ED icon
1225
CALL
Consolidated Edison
ED
$39.8B
$10.3M 0.01%
113,200

Similar funds

David Shaw's Q4 2023 Portfolio in Review

As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
  • David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
  • David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
  • David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
  • David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
  • David Shaw opened 575 new positions and closed 527 in Q4 2023.
  • David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.